Increased survival with high-dose multif
β
Brenda Shank; Howard Scher; Basil S. Hilaris; Carl Pinsky; Michelle Martin; Robe
π
Article
π
1985
π
John Wiley and Sons
π
English
β 813 KB
From June 1979 through April 1982, we treated 35 patients with limited small cell carcinoma on an intensive chemo-radio-immunotherapy regimen, consisting of induction with cyclophosphamide, doxorubicin, and vincristine, alternately cycled with VP-16 and cisplatin. Patients were stratified by perform